Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Novo Nordisk A/S Breaking News: Europe Biotech and Pharmaceuticals
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Amgen Inc Companies Pharmaceuticals
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Health care industry Amazon/com Inc Healthy Returns
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags LILLY DRN Business News Novo Nordisk A/S
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Breaking News: Business US: News LILLY DRN
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Business Susser Petroleum Partners LP Vistra Corp
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags LILLY DRN CVS Health Corp Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Amazon/com Inc State of Freight US: News
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Technology Health care industry Internet
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Biotech and Pharmaceuticals Health & Science Earnings
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Social issues Health & Science Health care industry
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Mad Money Investing Markets
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Earnings Business News LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Novo Nordisk A/S Elevance Health Inc Venture capital
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Novo Nordisk A/S Policy World Economy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Hospitals Illumina Inc IQVIA Holdings Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Abbvie Inc Biotech and Pharmaceuticals Teva Pharmaceutical Industries Ltd
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags LILLY DRN Novo Nordisk A/S Business News
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Labor economy Health & Science Cigna Corp
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Health & Science Social issues Business
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Novo Nordisk A/S Investment Strategy Stock Picks
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Doximity Inc Hims & Hers Health Inc Progyny Inc
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Business News Biotechnology LILLY DRN
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.